AG-221

3 Drugs Heading to the FDA Soon
Motley Fool
Mon, 12/12/16 - 09:34 am
FDA
Kite Pharma
KTE-C19
Flexion
Zilretta
AG-221
Agios Pharmaceuticals
Celgene
Agios Blood Cancer Drug Heading to Early FDA Filing by Partner Celgene
TheStreet.com
Wed, 09/7/16 - 08:16 pm
Agios
FDA
Celgene
acute myeloid leukemia
AG-221
Celgene and Agios Deliver Some Great "Bad" News
Investopedia
Thu, 06/18/15 - 09:15 am
Celgene
Agios
AG-348
AG-120
AG-221
blood cancer
Agios Pharma Plunges 15% Despite Strong Data for Leukemia Drug
Barron's
Fri, 06/12/15 - 10:52 pm
Agios Pharmaceuticals
AG-221
leukemia
Agios Pharmaceuticals announces AG-221 orphan drug designation
Yahoo/The Fly on the Wall
Mon, 06/16/14 - 09:58 am
Agios Pharmaceuticals
AG-221
acute myelogenous leukemia
leukemia
New Agios Clinical Data from Ongoing Phase 1 Trial of AG-221 Continue to Show Complete and Durable Remissions in Patients with Difficult to Treat Hematologic Malignancies
Yahoo/BusinessWire
Sat, 06/14/14 - 09:27 am
hematologic cancers
Agios Pharmaceuticals
AG-221
Bluebird, Agios: Preview of Next Week's Important Pipeline Updates
TheStreet.com
Fri, 06/6/14 - 09:34 am
Bluebird Bio
Agios
AG-221
Celgene
LentiGlobin
Agios' Experimental Leukemia Drug Makes Cancer Undetectable In Three Patients
Forbes
Mon, 04/7/14 - 08:34 am
Agios
AG-221
acute myeloid leukemia